(Q24248686)

5

object named as

Christopher Butler

0 references

author name string

Sander Koning

1

0 references

Arianne P Verhagen

2

0 references

Lisette WA van Suijlekom-Smit

3

0 references

Andrew D Morris

4

0 references

Johannes C van der Wouden

Cochrane Database of Systematic Reviews

6

0 references

publication date

22 April 2003

0 references

published in

0 references

cites work

Impetigo: a reassessment of etiology and therapy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

Impetigo contagiosa III. Comparative efficacy of oral erythromycin and topical mupirocin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

Azithromycin, erythromycin and cloxacillin in the treatment of infections of skin and associated soft tissues. European Azithromycin Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

Topical 2% mupirocin versus 2% fusidic acid ointment in the treatment of primary and secondary skin infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

Clinical pharmacology of cefadroxil in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

Randomized clinical trial of topical mupirocin versus oral erythromycin for impetigo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

Double-blind, double-dummy comparison of azithromycin and cephalexin in the treatment of skin and skin structure infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

Fusidic acid cream in the treatment of impetigo in general practice: double blind randomised placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

A comparative study of the efficacy, safety and tolerability of azithromycin and cefaclor in the treatment of children with acute skin and/or soft tissue infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

A comparative study of the efficacy, safety and tolerance of azithromycin, dicloxacillin and flucloxacillin in the treatment of children with acute skin and skin-structure infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

Cefdinir versus cephalexin for the treatment of skin and skin-structure infections. The Cefdinir Adult Skin Infection Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

Efficacy and safety of ampicillin/sulbactam and cefuroxime in the treatment of serious skin and skin structure infections in pediatric patients. UNASYN Pediatric Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

Treatment of skin and soft tissue infections with cefadroxil, a new oral cephalosporin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

Fleroxacin 400 mg once daily versus ofloxacin 400 mg twice daily in skin and soft tissue infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

Trimethoprim-polymyxin B sulphate cream compared with fusidic acid cream in the treatment of superficial bacterial infection of the skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

Amoxicillin combined with clavulanic acid for the treatment of soft tissue infections in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

Sultamicillin in the treatment of superficial skin and soft tissue infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

Evaluation of cefuroxime axetil and cefadroxil suspensions for treatment of pediatric skin infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

Comparative study of cephalexin hydrochloride and cephalexin monohydrate in the treatment of skin and soft tissue infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

Comparative studies of azithromycin in skin and soft-tissue infections and sexually transmitted infections by Neisseria and Chlamydia species

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

Comparative efficacy of cefotiam versus cephalothin in the therapy of skin and soft tissue infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

Tropical bacterial pyoderma in Vietnam. An improved therapeutic regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

Double-blind comparative study of two dosage regimens of cefaclor and amoxicillin-clavulanic acid in the outpatient treatment of soft tissue infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

Comparison of oral cefpodoxime proxetil and cefaclor in the treatment of skin and soft tissue infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

Mupirocin vs terbinafine in impetigo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

Comparison of mupirocin and erythromycin in the treatment of impetigo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

Prescribing antibiotics for impetigo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

Double-blind study comparing erythromycin and mupirocin for treatment of impetigo in children: implications of a high prevalence of erythromycin-resistant Staphylococcus aureus strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

Impetigo in childhood: changing epidemiology and new treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

Resistance to antibiotics used in dermatological practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

Scabies and Pyoderma in Lilongwe, Malawi. Prevalence and seasonal fluctuation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

Cefpodoxime Proxetil in the Treatment of Skin and Soft Tissue Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

Topical antibiotic treatment of impetigo with mupirocin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

7 January 2021

Guides for reading and interpreting systematic reviews: II. How did the authors find the studies and assess their quality?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

7 January 2021

Impetigo. Current etiology and comparison of penicillin, erythromycin, and cephalexin therapies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

7 January 2021

Double-blind randomized study of oral temafloxacin and cefadroxil in patients with mild to moderately severe bacterial skin infections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

7 January 2021

Systemic antimicrobial therapy in skin and skin structure infections: comparison of temafloxacin and ciprofloxacin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

7 January 2021

Azithromycin compared with cephalexin in the treatment of skin and skin structure infections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

7 January 2021

The treatment of streptococcal skin infections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

7 January 2021

Topical antibiotics in the treatment of superficial skin infections in general practice--a comparison of mupirocin with sodium fusidate

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

7 January 2021

Treatment of staphylococcal skin infections: a comparison of cephalexin and dicloxacillin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

7 January 2021

The Route of Antibiotic Administration in Superficial Impetigo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

7 January 2021

Post-streptococcal Glomerulonephritis Following Pyoderma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

7 January 2021

Cefadroxil in the treatment of skin and soft tissue infections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

7 January 2021

Resistance of staphylococci in The Netherlands: surveillance by an electronic network during 1989-1995

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

7 January 2021

Treatment of impetigo: a review

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

7 January 2021

Loracarbef vs. cefaclor in pediatric skin and skin structure infections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

7 January 2021

Comparison of oral cephalexin, topical mupirocin and topical bacitracin for treatment of impetigo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

7 January 2021

A clinical evaluation of neomycin in different bases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

7 January 2021

Multicenter, randomized study comparing levofloxacin and ciprofloxacin for uncomplicated skin and skin structure infections.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

7 January 2021

Co-operative double-blind trial of an antibiotic/corticoid combination in impetiginized atopic dermatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

7 January 2021

Clinical relevance of the antibacterial activity of terbinafine: a contralateral comparison between 1% terbinafine cream and 0.1% gentamicin sulphate cream in pyoderma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

7 January 2021

Topical mupirocin versus oral erythromycin in the treatment of primary and secondary skin infections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

7 January 2021

Topical mupirocin versus topical neosporin in the treatment of cutaneous infections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

7 January 2021

Treatment of impetigo and ecthyma. A comparison of sulconazole with miconazole

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

7 January 2021

Erythromycin versus cefadroxil in the treatment of skin infections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

7 January 2021

Impetigo contagiosa: a comparison of erythromycin and dicloxacillin therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

7 January 2021

Study of use of cefdinir versus cephalexin for treatment of skin infections in pediatric patients. The Cefdinir Pediatric Skin Infection Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

7 January 2021

A comparison of the new topical antibiotic mupirocin ('Bactroban') with oral antibiotics in the treatment of skin infections in general practice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

7 January 2021

A comparison of sodium fusidate ointment and mupirocin ointment in superficial skin sepsis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003261.PUB2

7 January 2021

10.1002/14651858.CD003261.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

3371510

3371510

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference